On November 15, 2020, Acacia Research Corporation ("Acacia") announced that it has completed the monetization of its Woodford Life Science portfolio.  The company announced today that it has agreed to pay approximately $1 billion to acquire Oxford Nanopore Technologies, a microcap company.  According to the company's press release announcing the acquisition, Acacia's cash and equity investments totaled $605 million in the third quarter of 2020.  The company also announced that it has entered into a six-month lockup for its remaining shares.  According to the SEC's complaint, Acacia's cash and equity investments totaled just over $1 billion in the third quarter of 2020.  As a result of the acquisition, Acacia's net asset value increased from $285 million in the third quarter of 2018 to $336 million in the fourth quarter of 2020.  The company's financial results, which were reported on November 15, 2020, reflect the impact of the acquisition of Oxford Nanopore Technologies.  As a result of the acquisition of Oxford Nanopore Technologies, Acacia's net asset value increased from about $285 million in the third quarter to $336 million in the fourth quarter.  As a result of the transaction, Acacia's net asset value increased by $33 million.  As a result of this transaction, Acacia's pro forma book value increased to $1 billion or $5.70 per share, up from $942.8 million or $5.70 per share as of June 30, 2021.  The company has entered into a six-month lockup agreement for its remaining shares until the expiry of the lockup.  The SEC's complaint, filed in the U.S. District Court for the Southern District of New York, charges Acacia with violating Section 17(a) of the Securities Act of 1933 and Section 10(b) of the Securities Exchange Act of 1934 and Rule 10b-5 thereunder.  The complaint also charges Acacia with violating Section 13(b) of the Exchange Act and Rule 12b-5 thereunder.  The complaint charges Acacia with violating Section 17(a)(2) of the Securities Act and Section 10(b) of the Exchange Act and Rule 10b-5 thereunder. The complaint charges Acacia with violating Section 17 (a) of the Securities Act and Section 10(a) of the Exchange Act and Rule 10b2-5 thereunder.  The complaint charges the company with violating Section 17(a) of the Exchange Act and Rule 12b2-3 thereunder.  The complaint charges Acacia for violating Section 17(a) of the